<DOC>
	<DOCNO>NCT01604018</DOCNO>
	<brief_summary>Cat allergy increasingly prevalent condition affect 10-15 % patient allergic rhinoconjunctivitis and/or asthma . The purpose optional observational follow-on study evaluate rhinoconjunctivitis symptom exposure cat dander EEC among subject complete dose visit study CP005 visit study CP005A approximately two year start treatment .</brief_summary>
	<brief_title>An Optional Two Year Follow Up Study Study CP005A</brief_title>
	<detailed_description>Subjects complete visit study CP005 CP005A invite attend Screening Visit CP005B . Subjects attend 4 visit EEC successive day . Following last EEC visit follow-up visit perform 3-10 day later .</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<criteria>Previously randomise study CP005 complete visit followon study CP005A `` Partly control '' `` uncontrolled '' asthma History anaphylaxis cat allergen Subjects FEV1 &lt; 70 % predicted Subjects tolerate baseline challenge EEC Treatment betablockers , alphaadrenoceptor blocker , tranquilizer , psychoactive drug Symptoms clinically relevant illness , Investigator 's opinion , within 6 week prior Screening Visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Cat Allergy</keyword>
	<keyword>Rhinoconjunctivitis</keyword>
</DOC>